Media – BioNet

An-Alternative-to-Pertussis-Combination-Vaccines-for-Booster-Use

An Alternative to Pertussis Combination Vaccines for Booster Use

Maternal-Immunisation-and-Passive-Protection-of-Newborns

February 9, 2026

Maternal Immunisation and Passive Protection of Newborns

bacteria-05022026-02

February 5, 2026

A Focused Strategy Against Pertussis Toxin

European Commission Grants EU Marketing Authorisation for a New Pertussis-Only Vaccine

February 1, 2026

Pertussis-Only Booster Vaccine Receives EU Marketing Authorisation

Clinical Evidence Supporting EU Authorisation

January 27, 2026

Clinical Evidence Supporting EU Authorisation

An-EU-Authorised-Pertussis-Only-Booster-Vaccine-for-Healthcare-Professionals

January 23, 2026

An EU-Authorised Pertussis-Only Booster Vaccine for Healthcare Professionals

EU-Authorised-Pertussis-Booster-Vaccination-for-Teenagers

January 20, 2026

EU-Authorised Pertussis Booster Vaccination for Teenagers

EU-GMP-certification

January 15, 2026

The European Commission Grants Marketing Authorisation for a First-of-its-Kind Pertussis-Only Vaccine

EU-GMP-certification

November 17, 2025

BioNet Achieves EU-GMP Certification for its Pertussis Vaccine Manufacturing

Poster-Press Conference-PreBoost-22(00)-04-2025

September 3, 2025

Clinical Study on Reduced-Dose Pertussis Vaccine in Thailand

Pertussis toxin-01

Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy

BioNet and Bio Farma Sign Strategic MoU

BioNet and Bio Farma Sign Strategic MoU to Expand TdaP Vaccine Access in ASEAN

Contact us and be part of the journey.

Our Location
Thailand
19 Soi Udomsuk 37, Bangkok 10260, Thailand

France
41 Cours de la Liberté 69003 Lyon Cedex 03

Social network